Mesirow Financial Investment Management, Inc.
Position in INTS — Intensity Therapeutics, Inc.
CIK 1469475
CHICAGO, IL
Position in INTS
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$57,883
-$25,130 QoQ
Shares Held
14,118
0.0% QoQ
Ownership
0.432%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 16 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INTS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Mesirow Financial Investment Management, Inc. holds $3,138,903 across 10 Biotechnology names. INTS ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,571 | $979,581 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
9,482 | $742,156 | |
| 3 | ICCC |
Immucell Corp /De/
|
42,481 | $426,934 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
628 | $311,946 | |
| 5 | NAMS |
NewAmsterdam Pharma Co N.V.
|
7,465 | $252,988 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
2,530 | $200,603 | |
| 7 | CSBR |
Champions Oncology, Inc.
|
15,800 | $97,328 | |
| 8 | INTS |
Intensity Therapeutics, Inc.
This page
|
14,118 | $57,883 |
All Filings in INTS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $57,883 | 14,118 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $83,013 | 14,118 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $102,910 | 251,000 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $48,600 | 200,000 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $33,770 | 110,000 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $78,800 | 40,000 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $35,200 | 20,000 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $168,756 | 44,177 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $216,467 | 44,177 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $229,720 | 44,177 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $292,896 | 34,177 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||